Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients

References

• Gao S, Gao L, Wang S, et al. ATF3 suppresses growth and metastasis of clear cell renal cell carcinoma by deactivating EGFR/AKT/GSK3β/β-catenin signaling pathway. Front Cell Dev Biol. 2021;9:618987.
   PubMed Web of Science ®Google Scholar
• Rossi SH, Klatte T Usher-Smith J, et al. Epidemiology and screening for renal cancer. World J Urol. 2018;36(9):1341–1353. doi:10.1007/s00345-018-2286-7
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang Z, Cheng G, et al. Development of a four-gene prognostic model for clear cell renal cell carcinoma based on transcriptome analysis. Genomics. 2021;113(4):1816–1827.
   PubMed Web of Science ®Google Scholar
• Lv Z, Qi L, Hu X, et al. Identification of a novel glycolysis-related gene signature correlates with the prognosis and therapeutic responses in patients with clear cell renal cell carcinoma. Front Oncol. 2021;11:633950. doi:10.3389/fonc.2021.633950
   PubMed Web of Science ®Google Scholar
• Marchioni M, Rivas JG, Autran A, et al. Biomarkers for renal cell carcinoma recurrence: state of the art. Curr Urol Rep. 2021;22(6):31. doi:10.1007/s11934-021-01050-0
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhang S, Guo H, et al. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma. Cell Commun Signal. 2021;19(1):39. doi:10.1186/s12964-021-00728-9
   PubMed Web of Science ®Google Scholar
• Lai Y, Zhao Z, Zeng T, et al. Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma. Cancer Cell Int. 2018;18(1):31. doi:10.1186/s12935-018-0530-2
   PubMed Web of Science ®Google Scholar
• Roskoski R Jr. Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas. Pharmacol Res. 2017;120:116–132. doi:10.1016/j.phrs.2017.03.010
   PubMed Web of Science ®Google Scholar
• Rassy E, Flippot R, Albiges L. Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma. Ther Adv Med Oncol. 2020;12:1758835920907504. doi:10.1177/1758835920907504
   Web of Science ®Google Scholar
• Motzer RJ, Banchereau R, Hamidi H, et al. Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade. Cancer Cell. 2020;38(6):803–817.e4. doi:10.1016/j.ccell.2020.10.011
   PubMed Web of Science ®Google Scholar
• Xu N, Ke Z-B, Lin X-D, et al. Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis. Cancer Cell Int. 2020;20(1):302. doi:10.1186/s12935-020-01343-3
   PubMed Web of Science ®Google Scholar
• Ke ZB, Wu YP, Huang P, et al. Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores. J Cell Physiol. 2021;236(1):706–713.
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–426. doi:10.1007/s10456-017-9562-9
   PubMed Web of Science ®Google Scholar
• Seles M, Hutterer GC, Foßelteder J, et al. Long non-coding RNA PANTR1 is associated with poor prognosis and influences angiogenesis and apoptosis in clear-cell renal cell cancer. Cancers. 2020;12(5):1200. doi:10.3390/cancers12051200
   PubMed Web of Science ®Google Scholar
• Chu G, Xu T, Zhu G, et al. Identification of a novel protein-based signature to improve prognosis prediction in renal clear cell carcinoma. Front Mol Biosci. 2021;8:623120. doi:10.3389/fmolb.2021.623120
   PubMed Web of Science ®Google Scholar
• Xing QW, Zeng TY, Liu SY, et al. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. BMC Cancer. 2021;21(1):381. doi:10.1186/s12885-021-08111-029
   Google Scholar
• Wang Y, Chen Y, Zhu B, et al. A novel nine apoptosis-related genes signature predicting overall survival for kidney renal clear cell carcinoma and its associations with immune infiltration. Front Mol Biosci. 2021;8:567730. doi:10.3389/fmolb.2021.567730
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang T, Tang J, et al. Construction of competitive endogenous RNA network and verification of 3-key LncRNA signature associated with distant metastasis and poor prognosis in patients with clear cell renal cell carcinoma. Front Oncol. 2021;11:640150. doi:10.3389/fonc.2021.640150
   PubMed Web of Science ®Google Scholar
• Guo Y, Li X, Zheng J, et al. Identification of a novel immune-related microRNA prognostic model in clear cell renal cell carcinoma. Transl Androl Urol. 2021;10(2):888–899. doi:10.21037/tau-20-1495
   PubMed Web of Science ®Google Scholar
• Zhou J, Liu G, Wu X, et al. A risk score model based on nine differentially methylated mRNAs for predicting prognosis of patients with clear cell renal cell carcinoma. Dis Markers. 2021;2021:8863799. doi:10.1155/2021/8863799
   PubMed Web of Science ®Google Scholar
• Wu Y, Wei X, Feng H, et al. Transcriptome analyses identify an RNA binding protein related prognostic model for clear cell renal cell carcinoma. Front Genet. 2020;11:617872. doi:10.3389/fgene.2020.617872
   PubMed Web of Science ®Google Scholar
• Dias F, Teixeira AL, Nogueira I, et al. Plasma extracellular vesicle-derived TIMP-1 mRNA as a prognostic biomarker in clear cell renal cell carcinoma: a Pilot Study. Int J Mol Sci. 2020;21(13):4624.
   PubMed Web of Science ®Google Scholar
• Armstrong AJ, Nixon AB, Carmack A, et al. Angiokines associated with outcomes after sunitinib or everolimus treatment in patients with non-clear cell renal cell carcinoma. Clin Cancer Res. 2021;27(12):3503–3503.
   PubMed Web of Science ®Google Scholar
• He L, Zhao X, Wang H, et al. RUNX3 mediates suppression of tumor growth and metastasis of human CCRCC by regulating cyclin related proteins and TIMP-1. PLoS One. 2012;7(3):e32961. doi:10.1371/journal.pone.0032961
   PubMed Web of Science ®Google Scholar
• Yang M, Zhang G, Wang Y, et al. Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer. Br J Cancer. 2020;123(9):1404–1416. doi:10.1038/s41416-020-1026-0
   PubMed Web of Science ®Google Scholar
• Hatano K, Saigo C, Kito Y, et al. Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma. Clin Exp Dent Res. 2020;6(2):174–180. doi:10.1002/cre2.267
   Google Scholar
• He W, Tang J, Li W, et al. Mutual regulation of JAG2 and PRAF2 promotes migration and invasion of colorectal cancer cells uncoupled from epithelial–mesenchymal transition. Cancer Cell Int. 2019;19(1):160. doi:10.1186/s12935-019-0871-5
   PubMed Web of Science ®Google Scholar
• Son MJ, Rho SB, Kim K, et al. Homeoprotein Msx1-PIASy interaction inhibits angiogenesis. Cells. 2020;9(8):1854. doi:10.3390/cells9081854
   PubMed Web of Science ®Google Scholar
• Yue Y, Yuan Y, Li L, et al. Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation. Int J Mol Med. 2018;41(5):2986–2996.
   PubMed Web of Science ®Google Scholar